Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Evidence: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial

Official URL: https://fevir.net/resources/Evidence/47665 Version: 1.0.0-ballot3
Standards status: Informative Computable Name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2012_DIBASY_trial
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#47665, OID:2.16.840.1.113883.4.642.40.44.22.47

Usage: Evidence Communication: ComparativeEvidence, Evidence Communication: SingleStudyEvidence

Copyright/Legal: https://creativecommons.org/licenses/by-nc-sa/4.0/

Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20), mean difference -2.04% (95% CI -2.53% to -1.55%)

version: 14; Last updated: 2023-12-06 17:44:57+0000

Profiles: ComparativeEvidence, SingleStudyEvidence

ArtifactPublicationStatus: Active

url: Evidence ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial

identifier: FEvIR Object Identifier/47665, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.47

version: 1.0.0-ballot3

name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Mingrone_2012_DIBASY_trial

title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial

citeAs:

ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Mingrone 2012 (DIBASY) trial [Evidence]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47665. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47665. Computable resource at: https://fevir.net/resources/Evidence/47665.

status: Active

date: 2022-05-29 11:06:42+0000

author: Brian S. Alper:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)ComparativeEvidence
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)SingleStudyEvidence

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

RelatesTos

-ExtensionTypeTarget[x]
*Derived Fromhttps://diabetesjournals.org/care/article/39/6/861/29305/Metabolic-Surgery-in-the-Treatment-Algorithm-for

description:

Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20), mean difference -2.04% (95% CI -2.53% to -1.55%)

variableDefinition

description:

60 patients aged 30-60 years with a body-mass index of 35 kg/m(2) or more and a history of type 2 diabetes lasting at least 5 years

variableRole: Population

observed: DIBASY Trial Enrollment Group

variableDefinition

description:

Roux-en-Y gastric bypass vs. medical treatment

variableRole: Exposure

comparatorCategory: medical treatment

observed: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment

variableDefinition

description:

HbA1c at 24 months

variableRole: Outcome

observed: OutcomeVariable: HbA1c at 24 months

synthesisType: not applicable

studyDesign: randomized assignment

statistic

description:

mean difference -2.04% (95% CI -2.53% to -1.55%)

note:

Mean HbA1c at 24 months in Mingrone 2012 was 5.65% in Surgery group (n = 20) and 7.69% in Medical/Lifestyle group (n = 20)

statisticType: Mean Difference

quantity: -2.04 % (Details: UCUM code% = '%')

SampleSizes

-NumberOfParticipantsKnownDataCount
*4040

AttributeEstimates

-DescriptionTypeLevelRange
*

95% CI -2.53% to -1.55%

Confidence interval0.95-2.53--1.55 %